Empirical Characteristics of Litigation Involving Tissue Plasminogen Activator and Ischemic Stroke
To access this article, please choose from the options below
Supervising editor: Robert Silbergleit, MD
Author contributions: BAL and JAZ conceived the study, designed the methods, and assessed the data. BAL performed the database searches, reviewed the cases, collated the data, and wrote the primary drafts. BAL and JAZ reviewed the drafts, edited the article, and finalized it. Both authors take responsibility for the paper as a whole.
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that my create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.
Publication dates: Available online March 7, 2008.
PII: S0196-0644(07)01873-2
doi:10.1016/j.annemergmed.2007.12.017
© 2008 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
